|
|
 | | | |
- close
- close
- close
- close
Arrhythmia Research Technology (HRT) |
QUOTE AND NEWS
OilVoice
May 22
Comment
HRT Participaccedilotildees em Petroacuteleo has announced its subsidiary HRT OG concluded the drillstem test of well 1HRT6AM on Block SOLT170 in the Solimotildees Basin. Well 1HRT6
Marketwire
May 17
Comment
FITCHBURG, MA -- (Marketwire) -- 05/17/12 -- Arrhythmia Research Technology, Inc. (the "Company") (NYSE MKT: HRT) (NYSE Amex: HRT) and its subsidiaries reported total revenue of $6,305,000 and net loss of $375,000 for the three months ended March 31,
Reuters
May 14
Comment
(In May 11 story, removes all references to company having first commercial oil output in 2012. HRT said the information was wrong and the result of an incorrect Portuguese translation of an HRT executive's comments on an English-language...
Reuters
May 14
Comment
(In May 11 story removes para 1 item of company having first commercial oil output in 2012. HRT said the information was wrong as the result of an incorrect Portuguese translation of an HRT executive's comments on an English-language conference...
Reuters
May 11
Comment
Brazil's HRT Participacoes em Petroleo SA expects to produce its first commercial petroleum by the end of 2012, Chief Financial Officer Lourenço Bastos-Tigre said on a conference call with investors Friday.
Reuters
May 11
Comment
Brazil's HRT
Participações em Petroleo SA is in talks with
companies to sell them gas from its fields in the Amazon region
to produce electricity or make...
MedPage Today
May 10
Comment
BOSTON (MedPage Today) -- The CHADS2 score -- used to determine stroke risk in patients with atrial fibrillation -- may help identify patients who will most benefit from statins for primary prevention of the arrhythmia, researchers found.
OilVoice
Apr 30
Comment
HRT Participaccedilotildees em Petroacuteleo S.A. BMFBOVESPA HRTP3 TSXV HRP announces that its subsidiary HRT OG Exploraccedilatildeo e Produccedilatildeo de Petroacuteleo Ltda
Marketwire
Apr 30
Comment
FITCHBURG, MA -- (Marketwire) -- 04/30/12 -- Arrhythmia Research Technology, Inc. (NYSE Amex: HRT) (the "Company"), a supplier of medical components, software and services, announced that the NYSE Amex LLC (the "Exchange"), by its letter dated April
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
| |||||||
